Wilmington PharmaTech Company LLC is a leading global service company specializing in the research and development of chemical process and medicinal chemistry for the pharmaceutical and biotechnology industries. Founded in 2003, WPT has a track record of reliable and quality services for pharma and biotech companies worldwide with state-of-the-art facilities and operations in the United States and China. Based on the established expertise and proprietary technologies, WPT has developed a wide range of capabilities for the research and development of today’s medicines, including custom synthesis, process chemistry, medicinal chemistry, API manufacturing, FTE research, polymorph screening and salt selection, and analytical services. WPT operates in the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries, providing crucial services to address the evolving needs of these sectors. With no publicly available information on the last investment or the investors involved, WPT's strategic direction and growth plans remain undisclosed. Nonetheless, the company's established position in the market and its commitment to innovation make it an intriguing prospect for potential investors seeking exposure to the pharmaceutical and biotechnology sectors.
There is no investment information
No recent news or press coverage available for Wilmington PharmaTech Company LLC.